2- (piperidin-1-yl) - 4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections

Details for Australian Patent Application No. 2009326141 (hide)

Owner AstraZeneca AB

Inventors Basarab, Gregory Steven; Hill, Pamela; Sherer, Brian; Zhou, Fei

Agent Davies Collison Cave

Pub. Number AU-A-2009326141

PCT Pub. Number WO2010/067123

Priority 61/121,953 12.12.08 US

Filing date 11 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/067123 Priority application(s): WO2010/067123

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009326143-2- (piperidin-1-yl) - 4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections

2009326132-Medicament delivery device